Perspective Therapeutics Inc (CATX)
2.665
-0.04
(-1.66%)
USD |
NYAM |
Oct 09, 15:23
Perspective Therapeutics Price : 2.665 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 08, 2026 | 2.43 | 2.73 | 2.37 | 2.71 | 3.255M |
| Oct 07, 2026 | 2.37 | 2.51 | 2.322 | 2.46 | 1.286M |
| Oct 06, 2026 | 2.59 | 2.60 | 2.30 | 2.36 | 2.703M |
| Oct 05, 2026 | 2.75 | 2.82 | 2.48 | 2.57 | 3.561M |
| Oct 02, 2026 | 2.77 | 2.82 | 2.685 | 2.76 | 2.622M |
| Oct 01, 2026 | 2.71 | 2.775 | 2.66 | 2.72 | 1.543M |
| Sep 30, 2026 | 2.64 | 2.775 | 2.55 | 2.75 | 1.670M |
| Sep 29, 2026 | 2.52 | 2.62 | 2.49 | 2.62 | 1.542M |
| Sep 28, 2026 | 2.50 | 2.575 | 2.46 | 2.50 | 1.505M |
| Sep 25, 2026 | 2.50 | 2.525 | 2.45 | 2.52 | 1.802M |
| Sep 24, 2026 | 2.58 | 2.59 | 2.44 | 2.50 | 1.698M |
| Sep 23, 2026 | 2.89 | 2.92 | 2.50 | 2.62 | 3.161M |
| Sep 22, 2026 | 3.00 | 3.02 | 2.814 | 2.96 | 5.145M |
| Sep 21, 2026 | 2.94 | 3.03 | 2.895 | 2.97 | 2.112M |
| Sep 18, 2026 | 2.89 | 2.94 | 2.77 | 2.88 | 11.64M |
| Sep 17, 2026 | 2.76 | 2.92 | 2.74 | 2.88 | 1.168M |
| Sep 16, 2026 | 2.73 | 2.75 | 2.62 | 2.70 | 1.582M |
| Sep 15, 2026 | 2.88 | 2.89 | 2.66 | 2.73 | 1.474M |
| Sep 14, 2026 | 2.81 | 2.96 | 2.79 | 2.92 | 2.024M |
| Sep 11, 2026 | 2.77 | 2.825 | 2.665 | 2.81 | 2.025M |
| Sep 10, 2026 | 2.96 | 3.01 | 2.75 | 2.77 | 1.583M |
| Sep 09, 2026 | 3.07 | 3.108 | 2.96 | 2.99 | 1.499M |
| Sep 08, 2026 | 3.12 | 3.18 | 3.02 | 3.12 | 1.061M |
| Sep 04, 2026 | 3.07 | 3.18 | 3.025 | 3.13 | 1.365M |
| Sep 03, 2026 | 3.09 | 3.14 | 3.03 | 3.12 | 931703.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 225.30 |
| Rigel Pharmaceuticals, Inc. | 49.34 |
| Enanta Pharmaceuticals, Inc. | 12.58 |
| Insight Molecular Diagnostics, Inc. | 3.37 |
| BridgeBio Pharma, Inc. | 65.38 |
Price Related Metrics
| PS Ratio | 607.43 |
| PEG Ratio | -4.825 |
| Price to Book Value | 0.9387 |
| Earnings Yield | -49.85% |
| Market Cap | 304.04M |
| PEGY Ratio | -4.825 |